Star Equity Holdings, Inc. (STRR)
NASDAQ: STRR · Real-Time Price · USD
10.92
+0.02 (0.18%)
At close: Nov 5, 2025, 4:00 PM EST
10.72
-0.20 (-1.83%)
After-hours: Nov 5, 2025, 5:56 PM EST
Star Equity Holdings Market Cap
Star Equity Holdings has a market cap or net worth of $38.22 million as of November 5, 2025. Its market cap has decreased by -10.29% in one year.
Market Cap
38.22M
Enterprise Value
22.35M
1-Year Change
-10.29%
Ranking
Category
Stock Price
$10.92
Market Cap Chart
Since March 18, 2003, Star Equity Holdings's market cap has decreased from $75.00M to $38.22M, a decrease of -49.05%. That is a compound annual growth rate of -2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 30.00M | -15.73% |
| Dec 31, 2024 | 35.60M | -18.35% |
| Dec 29, 2023 | 43.60M | -31.01% |
| Dec 30, 2022 | 63.20M | -19.49% |
| Dec 31, 2021 | 78.50M | 178.37% |
| Dec 31, 2020 | 28.20M | -19.66% |
| Dec 31, 2019 | 35.10M | -18.94% |
| Dec 31, 2018 | 43.30M | -38.41% |
| Dec 29, 2017 | 70.30M | 60.50% |
| Dec 30, 2016 | 43.80M | -56.59% |
| Dec 31, 2015 | 100.90M | -1.56% |
| Dec 31, 2014 | 102.50M | -23.56% |
| Dec 31, 2013 | 134.10M | -9.82% |
| Dec 31, 2012 | 148.70M | -5.53% |
| Dec 30, 2011 | 157.40M | -16.19% |
| Dec 31, 2010 | 187.80M | 48.34% |
| Dec 31, 2009 | 126.60M | 47.72% |
| Dec 31, 2008 | 85.70M | -60.16% |
| Dec 31, 2007 | 215.10M | -47.80% |
| Dec 29, 2006 | 412.10M | -2.02% |
| Dec 30, 2005 | 420.60M | 42.62% |
| Dec 31, 2004 | 294.90M | 46.28% |
| Dec 31, 2003 | 201.60M | 168.80% |
| Mar 18, 2003 | 75.00M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 845.25B |
| Johnson & Johnson | 448.90B |
| AbbVie | 377.67B |
| UnitedHealth Group | 294.38B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.09B |
| Novo Nordisk | 215.64B |